drugset / Trial / NCT01387464
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the aqueous humor concentration of bromfenac sodium in subjects administered multiple topical ocular doses of ISV-303 or Bromday™ QD prior to routine cataract surgery.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | 0.075 % | Topical |
| Subject | Bromfenac | Other / unclassified | 0.09 % | Topical |